Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

Ion Channels Modulating Mouse Dendritic Cell Functions

(2014) N. Matzner et al.   JOURNAL OF IMMUNOLOGY

A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events

(2009) David W. Brandes et al.   CURRENT MEDICAL RESEARCH AND OPINION

Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes

(2009) M. W. Pennington et al.   MOLECULAR PHARMACOLOGY

Study of membrane potential in T lymphocytes subpopulations using flow cytometry

(2008) Fernanda Mello de Queiroz et al.   BMC IMMUNOLOGY

Clonal CD8+ TCR-Vβ expanded populations with effector memory phenotype in Churg Strauss Syndrome

(2008) Giuseppe Guida et al.   CLINICAL IMMUNOLOGY

Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis

(2008) Dorin Capraru et al.   CLINICAL IMMUNOLOGY

Calcium signaling in lymphocytes

(2008) Masatsugu Oh-hora et al.   CURRENT OPINION IN IMMUNOLOGY

The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies

(2008) Michael K Racke   CURRENT OPINION IN NEUROLOGY

Disease-Modifying Agents for Multiple Sclerosis

(2008) Til Menge et al.   DRUGS

Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block

(2008) Melanie P. Matheu et al.   IMMUNITY

TWIK-related Acid-sensitive K+Channel 1 (TASK1) and TASK3 Critically Influence T Lymphocyte Effector Functions

(2008) Sven G. Meuth et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Kv1.5 Association Modifies Kv1.3 Traffic and Membrane Localization

(2008) Rubén Vicente et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

(2008) Daniel D Mikol et al.   LANCET NEUROLOGY

Molecular Clustering of STIM1 with Orai1/CRACM1 at the Plasma Membrane Depends Dynamically on Depletion of Ca2+ Stores and on Electrostatic Interactions

(2008) Nathaniel Calloway et al.   MOLECULAR BIOLOGY OF THE CELL

Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation

(2008) Riina M. Luik et al.   NATURE

Calcium signaling in immune cells

(2008) Monika Vig et al.   NATURE IMMUNOLOGY

Disease-modifying therapy in multiple sclerosis: Update and clinical implications

(2008) D. S. Goodin   NEUROLOGY

Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

(2008) D. S. Goodin et al.   NEUROLOGY

TRESK-like potassium channels in leukemic T cells

(2008) Igor I. Pottosin et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Clofazimine Inhibits Human Kv1.3 Potassium Channel by Perturbing Calcium Oscillation in T Lymphocytes

(2008) Yunzhao R. Ren et al.   PLoS One

Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation

(2008) M. I. Lioudyno et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification and development of new therapeutics for multiple sclerosis

(2008) Ralf A. Linker et al.   TRENDS IN PHARMACOLOGICAL SCIENCES